Vascular Stent Market - Global Vascular Stent Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Type, By Material, By End User, By Geographic Coverage and By Company)

Description

The global vascular stent market is projected to reach US$17.1 billion by 2032, growing from US$14.2 billion in 2025, at a CAGR of 7.3% from 2025 to 2032. The rising prevalence of cardiovascular diseases, coupled with technological advancements in stent materials and designs, is expected to drive market growth significantly. The increasing preference for minimally invasive procedures and innovations in bio-absorbable stents further enhance the market outlook.

Market Insights

Drug-eluting stents (DES) are expected to hold over 55% of the market share by 2025 due to their superior ability to prevent restenosis.
Rising incidences of coronary artery disease (CAD) and atherosclerosis are boosting the demand for vascular stents globally.
Bio-absorbable and combination-material stents are revolutionizing the industry by enhancing safety and efficacy.
North America dominates the market due to its advanced healthcare infrastructure, while Asia Pacific emerges as the fastest-growing region due to rising healthcare investments and disease prevalence.
The growing healthcare infrastructure in Asia Pacific and Latin America presents lucrative opportunities for market expansion.
Increased demand for minimally invasive procedures continues to boost global stent adoption.
Biocompatibility and long-term safety remain key focus areas for new stent designs and material innovations.

Drivers Fueling Market Growth

1. Increasing Preference for Minimally Invasive Techniques

The vascular stent market is witnessing substantial growth due to the increasing preference for minimally invasive surgical techniques. Angioplasty and similar procedures are gaining popularity due to benefits such as reduced recovery times, lower postoperative complications, and smaller incisions. The rising number of percutaneous coronary interventions (PCIs)-with over 1 million procedures performed annually in the U.S. alone-further illustrates the critical role of vascular stents in modern cardiovascular care.

2. Advancements in Stent Technologies

Technological advancements in stents are shaping the market Analysis. Drug-eluting stents (DES), which release medication to prevent restenosis, significantly improve patient outcomes compared to bare-metal stents. Innovations in bio-absorbable stents that dissolve after fulfilling their purpose are gaining traction, reducing long-term complications. Furthermore, advanced imaging and delivery systems, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT), enhance precision in stent placement, reducing procedural risks.

Key Business Opportunities

1. Bioresorbable Vascular Scaffold Stents

Bio-absorbable vascular scaffold (BRS) stents present a significant market opportunity as they offer temporary mechanical support before dissolving naturally. This reduces foreign material presence in the body, minimizing long-term complications. As regulatory approvals increase and production costs decrease, bio-absorbable stents are expected to become a key growth driver.

2. Integration of AI and Robotics

Artificial intelligence (AI) and robotics are transforming interventional cardiology. AI-powered imaging tools improve stent placement precision, while robotic-assisted procedures enhance accuracy and consistency, reducing complications. The integration of these technologies is expected to drive demand for next-generation vascular stents with improved performance.

Challenges and Barriers

1. High Cost of Stent Procedures

The high cost of vascular stents and related procedures remains a major restraint, particularly in low- and middle-income countries. Advanced stents such as drug-eluting and bio-absorbable stents come at premium prices, limiting accessibility for patients without adequate insurance coverage.

2. Stringent Regulatory Requirements

The rigorous approval process for vascular stents delays market entry for new products. Compliance with regional regulatory standards adds further challenges for manufacturers looking to commercialize products globally.

Regional Analysis

North America: Market Leader

North America continues to dominate the global vascular stent market due to its high burden of cardiovascular diseases (CVDs), advanced healthcare systems, and favorable reimbursement policies. The presence of key industry players and strong R&D investments further enhance regional market growth.

Europe: Second Largest Market

Europe holds the second-largest share, with Germany, the UK, and France leading the market. The region benefits from robust healthcare infrastructure, high awareness of vascular diseases, and a growing preference for minimally invasive procedures. Regulatory frameworks such as CE marking ensure high safety and efficacy standards, driving adoption.

Asia Pacific: Fastest Growing Region

Asia Pacific is the fastest-growing region, driven by rising healthcare investments, increasing disease prevalence, and improving access to advanced medical technologies. Countries like China, India, and Japan are witnessing substantial demand for vascular stents due to growing healthcare infrastructure and increasing patient awareness.

Latin America and Middle East & Africa: Emerging Markets

These regions present significant growth potential due to government initiatives to improve healthcare access, rising incidence of cardiovascular diseases, and increasing healthcare expenditures.

Key Players Shaping the Market

The vascular stent market is highly competitive, with major companies focusing on innovation, strategic mergers, and acquisitions to strengthen their market position. Key players include:

Medtronic
Abbott Laboratories
Cardiovascular Systems, Inc.
Boston Scientific Corporation
AngioDynamics
Edwards Lifesciences Corporation
Biosensors International Group, Ltd.
W.L. Gore & Associates, Inc.
Merit Medical Systems

Recent Industry Developments

May 2024: Abbott Laboratories launched the XIENCE Sierra Everolimus Drug-Eluting Coronary Stent System in India, expanding its portfolio of advanced stent technologies.
January 2023: BioMatrix(TM) Alpha introduced a new stent platform with an innovative pro-healing coating, improving biocompatibility and reducing complications.

Segmentation of the Global Vascular Stent Market

By Type:

Drug-Eluting Stents (DES)
Bare-Metal Stents
Bio-absorbable Stents

By Material:

Metal
Polymeric
Combination

By End User:

Hospitals
Ambulatory Surgery Centers (ASCs)
Specialty Clinics

By Region:

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

1. Executive Summary

1.1. Global Vascular Stent Market Snapsshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Economic Overview
2.7. PESTLE Analysis

3. Price Analysis, 2025

3.1. Global Average Price Analysis, by Type, US$ Per Unit, 2025
3.2. Prominent Factor Affecting Vascular Stent Market Prices
3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Vascular Stent Market Outlook, 2019 - 2032

4.1. Global Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 4.1.1. Key Highlights
  - 4.1.1.1. Drug-Eluting Stents
  - 4.1.1.2. Bare-Metal Stents
  - 4.1.1.3. Bio absorbable Stents
  - 4.1.1.4. Others
4.2. Global Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 4.2.1. Key Highlights
  - 4.2.1.1. Metal
  - 4.2.1.2. Polymeric
  - 4.2.1.3. Combination
4.3. Global Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 4.3.1. Key Highlights
  - 4.3.1.1. Hospitals
  - 4.3.1.2. Ambulatory Surgery Centers (ASCs)
  - 4.3.1.3. Specialty Clinics
4.4. Global Vascular Stent Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 4.4.1. Key Highlights
  - 4.4.1.1. North America
  - 4.4.1.2. Europe
  - 4.4.1.3. Asia Pacific
  - 4.4.1.4. Latin America
  - 4.4.1.5. Middle East & Africa

5. North America Vascular Stent Market Outlook, 2019 - 2032

5.1. North America Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 5.1.1. Key Highlights
  - 5.1.1.1. Drug-Eluting Stents
  - 5.1.1.2. Bare-Metal Stents
  - 5.1.1.3. Bio absorbable Stents
  - 5.1.1.4. Others
5.2. North America Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 5.2.1. Key Highlights
  - 5.2.1.1. Metal
  - 5.2.1.2. Polymeric
  - 5.2.1.3. Combination
5.3. North America Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 5.3.1. Key Highlights
  - 5.3.1.1. Hospitals
  - 5.3.1.2. Ambulatory Surgery Centers (ASCs)
  - 5.3.1.3. Specialty Clinics
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. North America Vascular Stent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 5.4.1. Key Highlights
  - 5.4.1.1. U.S. Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 5.4.1.2. U.S. Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 5.4.1.3. U.S. Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 5.4.1.4. Canada Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 5.4.1.5. Canada Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 5.4.1.6. Canada Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Vascular Stent Market Outlook, 2019 - 2032

6.1. Europe Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 6.1.1. Key Highlights
  - 6.1.1.1. Drug-Eluting Stents
  - 6.1.1.2. Bare-Metal Stents
  - 6.1.1.3. Bio absorbable Stents
  - 6.1.1.4. Others
6.2. Europe Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 6.2.1. Key Highlights
  - 6.2.1.1. Metal
  - 6.2.1.2. Polymeric
  - 6.2.1.3. Combination
6.3. Europe Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospitals
  - 6.3.1.2. Ambulatory Surgery Centers (ASCs)
  - 6.3.1.3. Specialty Clinics
- 6.3.2. Attractiveness Analysis
6.4. Europe Vascular Stent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 6.4.1. Key Highlights
  - 6.4.1.1. Germany Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.2. Germany Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 6.4.1.3. Germany Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 6.4.1.4. U.K. Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.5. U.K. Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 6.4.1.6. U.K. Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 6.4.1.7. France Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.8. France Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 6.4.1.9. France Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 6.4.1.10. Italy Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.11. Italy Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 6.4.1.12. Italy Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 6.4.1.13. Turkey Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.14. Turkey Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 6.4.1.15. Turkey Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 6.4.1.16. Russia Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.17. Russia Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 6.4.1.18. Russia Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 6.4.1.19. Rest of Europe Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 6.4.1.20. Rest of Europe Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 6.4.1.21. Rest of Europe Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Vascular Stent Market Outlook, 2019 - 2032

7.1. Asia Pacific Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 7.1.1. Key Highlights
  - 7.1.1.1. Drug-Eluting Stents
  - 7.1.1.2. Bare-Metal Stents
  - 7.1.1.3. Bio absorbable Stents
  - 7.1.1.4. Others
7.2. Asia Pacific Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 7.2.1. Key Highlights
  - 7.2.1.1. Metal
  - 7.2.1.2. Polymeric
  - 7.2.1.3. Combination
7.3. Asia Pacific Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospitals
  - 7.3.1.2. Ambulatory Surgery Centers (ASCs)
  - 7.3.1.3. Specialty Clinics
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Asia Pacific Vascular Stent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 7.4.1. Key Highlights
  - 7.4.1.1. China Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.2. China Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 7.4.1.3. China Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 7.4.1.4. Japan Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.5. Japan Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 7.4.1.6. Japan Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 7.4.1.7. South Korea Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.8. South Korea Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 7.4.1.9. South Korea Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 7.4.1.10. India Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.11. India Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 7.4.1.12. India Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 7.4.1.13. Southeast Asia Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.14. Southeast Asia Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 7.4.1.15. Southeast Asia Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 7.4.1.16. Rest of Asia Pacific Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 7.4.1.17. Rest of Asia Pacific Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 7.4.1.18. Rest of Asia Pacific Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Vascular Stent Market Outlook, 2019 - 2032

8.1. Latin America Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 8.1.1. Key Highlights
  - 8.1.1.1. Drug-Eluting Stents
  - 8.1.1.2. Bare-Metal Stents
  - 8.1.1.3. Bio absorbable Stents
  - 8.1.1.4. Others
8.2. Latin America Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 8.2.1. Key Highlights
  - 8.2.1.1. Metal
  - 8.2.1.2. Polymeric
  - 8.2.1.3. Combination
8.3. Latin America Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 8.3.1. Key Highlights
  - 8.3.1.1. Hospitals
  - 8.3.1.2. Ambulatory Surgery Centers (ASCs)
  - 8.3.1.3. Specialty Clinics
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Latin America Vascular Stent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 8.4.1. Key Highlights
  - 8.4.1.1. Brazil Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.2. Brazil Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 8.4.1.3. Brazil Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 8.4.1.4. Mexico Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.5. Mexico Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 8.4.1.6. Mexico Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 8.4.1.7. Argentina Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.8. Argentina Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 8.4.1.9. Argentina Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 8.4.1.10. Rest of Latin America Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 8.4.1.11. Rest of Latin America Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 8.4.1.12. Rest of Latin America Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Vascular Stent Market Outlook, 2019 - 2032

9.1. Middle East & Africa Vascular Stent Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 9.1.1. Key Highlights
  - 9.1.1.1. Drug-Eluting Stents
  - 9.1.1.2. Bare-Metal Stents
  - 9.1.1.3. Bio absorbable Stents
  - 9.1.1.4. Others
9.2. Middle East & Africa Vascular Stent Market Outlook, by Material, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 9.2.1. Key Highlights
  - 9.2.1.1. Metal
  - 9.2.1.2. Polymeric
  - 9.2.1.3. Combination
9.3. Middle East & Africa Vascular Stent Market Outlook, by End User, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 9.3.1. Key Highlights
  - 9.3.1.1. Hospitals
  - 9.3.1.2. Ambulatory Surgery Centers (ASCs)
  - 9.3.1.3. Specialty Clinics
- 9.3.2. BPS Analysis/Market Attractiveness Analysis
9.4. Middle East & Africa Vascular Stent Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
- 9.4.1. Key Highlights
  - 9.4.1.1. GCC Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.2. GCC Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 9.4.1.3. GCC Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 9.4.1.4. South Africa Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.5. South Africa Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 9.4.1.6. South Africa Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 9.4.1.7. Egypt Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.8. Egypt Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 9.4.1.9. Egypt Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 9.4.1.10. Nigeria Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.11. Nigeria Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 9.4.1.12. Nigeria Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
  - 9.4.1.13. Rest of Middle East & Africa Vascular Stent Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  - 9.4.1.14. Rest of Middle East & Africa Vascular Stent Market by Material, Value (US$ Bn), 2019 - 2032
  - 9.4.1.15. Rest of the Middle East & Africa Vascular Stent Market by End User, Value (US$ Bn), 2019 - 2032
- 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

10.1. Company Market Share Analysis, 2025
10.2. Competitive Dashboard
10.3. Company Profiles
- 10.3.1. Medtronic
  - 10.3.1.1. Company Overview
  - 10.3.1.2. Product Portfolio
  - 10.3.1.3. Financial Overview
  - 10.3.1.4. Business Strategies and Development
- 10.3.2. Abbott
  - 10.3.2.1. Company Overview
  - 10.3.2.2. Product Portfolio
  - 10.3.2.3. Financial Overview
  - 10.3.2.4. Business Strategies and Development
- 10.3.3. Cardiovascular Systems, Inc.
  - 10.3.3.1. Company Overview
  - 10.3.3.2. Product Portfolio
  - 10.3.3.3. Financial Overview
  - 10.3.3.4. Business Strategies and Development
- 10.3.4. Boston Scientific Corporation
  - 10.3.4.1. Company Overview
  - 10.3.4.2. Product Portfolio
  - 10.3.4.3. Financial Overview
  - 10.3.4.4. Business Strategies and Development
- 10.3.5. AngioDynamics
  - 10.3.5.1. Company Overview
  - 10.3.5.2. Product Portfolio
  - 10.3.5.3. Financial Overview
  - 10.3.5.4. Business Strategies and Development
- 10.3.6. Edwards Lifesciences Corporation
  - 10.3.6.1. Company Overview
  - 10.3.6.2. Product Portfolio
  - 10.3.6.3. Financial Overview
  - 10.3.6.4. Business Strategies and Development
- 10.3.7. Biosensors International Group, Ltd.
  - 10.3.7.1. Company Overview
  - 10.3.7.2. Product Portfolio
  - 10.3.7.3. Financial Overview
  - 10.3.7.4. Business Strategies and Development
- 10.3.8. W. L. Gore & Associates, Inc.
  - 10.3.8.1. Company Overview
  - 10.3.8.2. Product Portfolio
  - 10.3.8.3. Financial Overview
  - 10.3.8.4. Business Strategies and Development
- 10.3.9. Merit Medical Systems.
  - 10.3.9.1. Company Overview
  - 10.3.9.2. Product Portfolio
  - 10.3.9.3. Financial Overview
  - 10.3.9.4. Business Strategies and Development
- 10.3.10. Others
  - 10.3.10.1. Company Overview
  - 10.3.10.2. Product Portfolio
  - 10.3.10.3. Financial Overview
  - 10.3.10.4. Business Strategies and Development

11. Appendix

11.1. Research Methodology
11.2. Report Assumptions
11.3. Acronyms and Abbreviations